Esophagectomy:Three-field Versus Two-field Lymphadenectomy (ECTOP-2002)
Esophagectomy: Three-field Lymphadenectomy Versus. Two-field Lymphadenectomy for Thoracic Middle and Lower Esophageal Cancer
Sponsor: Fudan University
A NA clinical study on Esophageal Neoplasms, this trial is completed. The trial is conducted by Fudan University and has accumulated 10 data snapshots since 2013. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Aug 2023 — Jul 2024 [monthly]
Completed NA
Status: Unknown Status → Completed
-
Oct 2021 — Aug 2023 [monthly]
Unknown Status NA
Status: Active Not Recruiting → Unknown Status
-
Jan 2021 — Oct 2021 [monthly]
Active Not Recruiting NA
▶ Show 5 earlier versions
-
Mar 2019 — Jan 2021 [monthly]
Active Not Recruiting NA
-
Feb 2019 — Mar 2019 [monthly]
Active Not Recruiting NA
Phase: PHASE3 → NA
-
Jun 2018 — Feb 2019 [monthly]
Active Not Recruiting PHASE3
-
Aug 2017 — Jun 2018 [monthly]
Active Not Recruiting PHASE3
-
Jan 2017 — Aug 2017 [monthly]
Active Not Recruiting PHASE3
First recorded
Mar 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Fudan University
For direct contact, visit the study record on ClinicalTrials.gov .